ARG1 is associated with reduced cardiometabolic risk in patients with rheumatoid arthritis: a cis-instrument Mendelian randomisation proteomic analysis

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Improving cardiovascular risk prediction in rheumatoid arthritis Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology